Brisight Nord
Latest round
- Series A
Last raised
- Aug 2025
Total raised
- Undisclosed
Investors
- 2
About Brisight Nord
Based in Wuxi, China, and established in 2021, Brisight Nord is a medical equipment company that focuses on ophthalmic medical equipment. It employed Tsinghua University professors as guiding experts. And team members were from the Beijing University of Technology and Chinese Academy of Sciences. Brisight Nord provides medical devices for ophthalmic surgery. Its products include vitrectomy machines, ultrasound machines, artificial crystals, excimer lasers, and others support consumables. The company generates revenue from developing medical devices.
Who invested in Brisight Nord
2 investors across 2 rounds
See all investors in Brisight Nord
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Brisight Nord
Who invested in Brisight Nord?
Brisight Nord has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Brisight Nord raised?
Brisight Nord has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Brisight Nord last raise money?
Brisight Nord's most recent round on record is a Series A, in Aug 2025.
What does Brisight Nord do?
Based in Wuxi, China, and established in 2021, Brisight Nord is a medical equipment company that focuses on ophthalmic medical equipment.
Where is Brisight Nord headquartered?
Brisight Nord is headquartered in Wuxi, China.
Which VCs invest in companies like Brisight Nord?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Brisight Nord's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Brisight Nord? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.